Testicular, Penile, and Rare GU Malignancies COE

The Management of Primary Carcinoma of The Urethra - Reza Mehrazin

Details
In a presentation, followed by an educational discussion, from Reza Mehrazin, MD, the topic of management of primary urothelial carcinoma is discussed in depth. Dr. Mehrazin began his presentation with epidemiology and risk factors for this aggressive disease. He discussed the risk factor of advanced age (>60 years old) along with other less-known risk factors, such as chronic urethral irritation....

Longer-Term Outcomes of Patients with Testicular Cancer: Late Relapses and Toxicities - Sia Daneshmand

Details
In this conversation with Alicia Morgans, MD, MPH, Siamak (Sia) Daneshmand discusses long-term follow-up of testicular cancer patients, a topic of interest to many navigating testicular cancer survivorship. Dr. Daneshmand provided an oral abstract discussion during the 2021 ASCO annual meeting highlighting two abstracts Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in...

Results From the IGCCCG Update Consortium in Metastatic Seminoma And Nonseminomatous Germ Cell Tumors – Silke Gillessen

Details
Silke Gillessen highlights the International Germ Cell Cancer Collaborative Group (IGCCCG) update model for both seminoma and non-seminoma patients highlighting two recently published articles in the Journal of Clinical Oncology, titled "Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium" and "Survival and New Prognosticat...

Clinical Trials and Developments in Testicular Cancer - Darren Feldman

Details
Darren Feldman, MD, and Charles Ryan, MD, discuss multiple topics in this conversation on testicular germ cell tumors ranging from risk factors, developments in treatment, and the global TIGER study. There is limited data for the association of testis cancer with hereditary cancer genes. In this conversation, Daren Feldman highlights developments in treatment for testicular cancer including the in...

Testicular Cancer Survivorship & Advocacy - Scott Petinga

Details
Scott Petinga, a testicular cancer survivor, patient advocate, and entrepreneur, joins Charles Ryan, MD, to provide an update on his work in the field of testicular cancer advocacy. Scott Petinga shares research advances he is a part of at USC as well as different patient resource avenues like social media groups and online forums for newly diagnosed patients and testicular cancer survivors. Biogr...

Survivorship in Testicular Cancer - Mary Dunn

Details
The Testicular Cancer Survivorship Clinic, lead by Adult Nurse Practitioner, Mary Dunn is designed to help patients transition from testicular cancer treatment to testicular cancer survivorship. The Testicular Cancer Survivorship Clinic was established in 2008, at the University of North Carolina. Patients who have completed definitive therapy for testicular cancer are transitioned into the clinic...

Survivorship Care Plans Addressing Long-term Mental Health Among Survivors of Testicular Cancer, Journal Club - Christopher Wallis & Zachary Klaassen

Details
Testicular cancer survivors may experience mental illness as a consequence of their cancer diagnosis and treatment. A recently published article titled, "Long-Term Mental Health Service Utilization Among Survivors of Testicular Cancer: A Population-Based Cohort Study" focuses on survivorship care plans for testicular cancer patients. In this UroToday Journal Club, Christopher Wallis, MD, Ph.D., an...

Surgery In Early Metastatic Seminoma - Siamak Daneshmand

Details
The management of stage 2A seminoma has been consistent over the past several years, consisting of either radiotherapy or primary chemotherapy. Cure rates with these approaches are excellent but are also associated with many life years of potential cumulative toxicities. At the 2021 GU ASCO meeting, Dr. Siamak Daneshmand presented a phase 2 study in stage two seminoma, the Surgery In Early Metasta...

Global Society of Rare Genitourinary Tumors (GSRGT) - Andrea Necchi & Philippe Spiess

Details
Andrea Necchi, MD, and Philippe Spiess, MD, MS, FRCS(C), FACS, join Alicia Morgans, MD, MPH, to discuss the new international effort to develop a Global Society of Rare Genitourinary (GU) Cancers. The Global Society of Rare Genitourinary Tumors (GSRGT) will have both an educational and research mission to promote evidence-based diagnostic and treatment standards across the world through conference...

Insights on the Management of Penile Cancer - Philippe Spiess & Jad Chahoud

Details
Philippe Spiess, MD, MS, FRCS(C), FACS, and Jad Chahoud, MD, MPH present expert insight on the management of penile cancers in a conversation with Ashish Kamat, MD, MBBS. Dr. Spiess focuses the discussion on treatment options for advanced penile cancer but starts by laying out updates to the staging of the disease. He also describes how human papillomavirus (HPV) positive or negative cancers have...